Further analysis showed that the miR-9 has a regulatory action on the ABCB1 and there is a negative correlation between miR-9 and this ABC transporter in drug-resistant CML cells [139]. This evidence concerns the gene ABCB1 and chronic myelogenous leukemia, BCR-ABL1 positive.